IDH2 and glioblastoma: Heterozygous mutations in catalytic arginine residues of isocitrate dehydrogenases (IDHs) 1 and 2 (IDH1 and IDH2) have been identified during exome-sequencing studies of glioblastoma tumors in 2008 (1).